Current location - Education and Training Encyclopedia - Resume - Expert Group of No.210 Hospital of China People's Liberation Army
Expert Group of No.210 Hospital of China People's Liberation Army
Attending physician of otolaryngology; Master student of Hubei Medical University

Personal profile

Attending physician, engaged in clinical work in otolaryngology for many years, devoted to the basic and clinical diagnosis and treatment research of cutting-edge technology in otolaryngology.

Be especially good at

He is good at minimally invasive treatment of allergic rhinitis, turbinate hypertrophy, chronic pharyngitis, vocal cord polyps and other diseases with Coblator II low temperature plasma technology and Richard Wolf endoscope. He is especially good at minimally invasive treatment of snoring caused by adenoid hypertrophy in children, correction of nasal septum deviation and cosmetic surgery.

Its high-quality medical level and enthusiastic working attitude are well received by patients. Director of Oncology Department, member of shenyang military area command Science and Technology Committee; Member of the Standing Committee of Bioengineering Society for Targeted Tumor Therapy.

Be especially good at

Good at targeted tumor therapy; He is good at using tumor immune cell therapy technology to treat unresectable tumors in the middle and late stage, effectively improving the tolerance of radiotherapy and chemotherapy, reducing side effects, improving the quality of life of patients and prolonging the life cycle.

achievements in scientific research

It has undertaken two national-level projects, one in Dalian, namely, clinical research on immune targeted radiotherapy, microwave ablation sequential individualized chemotherapy for advanced non-small cell cancer and intratumoral immune targeted radiotherapy combined with biological immunotherapy for advanced cancer.

Personal profile

1983 graduated from the fourth military medical university with clinical major. After graduation, I worked in pathology teaching and scientific research for three years and engaged in clinical work 13. He used to be the director of the medical department of 2 10 hospital and the vice president of medical treatment, responsible for the management of hospital medical services. He is also the director of minimally invasive tumor surgery. In 2008, he served as the director of tumor surgery and won the first prize of scientific and technological progress in Liaoning Province and the military scientific and technological progress award. Member of Biotherapy Committee of China Anti-cancer Association and Lung Cancer Committee of Heilongjiang Anti-cancer Association.

Be especially good at

He is good at the combined application of tumor biotherapy and radiotherapy and chemotherapy, especially at the individualized treatment of various solid tumors. He has rich clinical experience in the application of biological immunotherapy for digestive tract tumors and respiratory tract tumors such as gastric cancer, esophageal cancer, colorectal cancer, lung cancer and nasopharyngeal carcinoma, and has formed a unique treatment system and achieved remarkable clinical results.

achievements in scientific research

He has published many articles in Chinese Journal of Cardiology and Journal of Oncology. 22 new scientific research projects and new medical technologies carried out at or above the provincial level.

Personal profile

1970 graduated from Bethune University of Jilin University. After graduation, he worked in the oncology department of the Second Hospital of Baiyi Medical University for 40 years, and devoted himself to the clinical and research of tumor biological immunotherapy for a long time. I have mastered how to properly combine biological therapy with surgery, radiotherapy and chemotherapy, and achieved remarkable results in the treatment of gastric cancer, esophageal cancer, colorectal cancer, lung cancer and nasopharyngeal cancer by using biological immunotherapy. He has accumulated rich experience in long-term clinical work and won unanimous praise from patients and industry experts. 2/Deputy Director of Oncology Department of KLOC-0/0 Hospital; Member of Cancer Branch of Dalian Medical Association

Be especially good at

Good at internal and surgical treatment and comprehensive treatment of various solid tumors; He has rich experience and profound attainments in biological cell immunotherapy, the fourth largest tumor treatment technology.

achievements in scientific research

Published more than 20 papers in provincial and national magazines. His research achievement "Systematic research on the treatment and prevention of bladder cancer with Brucea javanica oil emulsion" won the third prize of military medical achievement.

Personal profile

Graduated from the Third Military Medical University, party member, deputy chief physician. He has rich clinical practice and research experience in the surgical treatment of renal cancer, bladder cancer and prostate cancer, as well as chemotherapy, molecular targeted therapy combined with biotherapy for renal cancer, bladder cancer, prostate cancer, breast cancer and lung cancer, and has unique research and exquisite technology for tumor biological immunotherapy. Deputy chief physician of oncology department; Member of Clinical Oncology Collaboration Committee of Anti-cancer Association; Member of the Professional Committee of Integrated Traditional Chinese and Western Medicine Treatment of Tumors; Member of the Professional Committee of Chemotherapy for the Elderly.

Be especially good at

He is good at the diagnosis of breast cancer, lung cancer, gastrointestinal tumor, malignant lymphoma and other tumors, the determination of radiotherapy and chemotherapy plan and the formulation of comprehensive treatment plan. He has unique views on biological treatment of tumors and is proficient in comprehensive treatment of chemotherapy and biological immunotherapy.

achievements in scientific research

There are papers published in China Cancer Rehabilitation and Research, Correlation between Taxanes' Efficacy in Treating Advanced Breast Cancer and Molecular Phenotype Differences, and China Medical Innovation, Clinical Study of Gefitinib in Treating Advanced Non-small Cell Lung Cancer.

Personal profile

1994 graduated from Dalian medical university with a master's degree in clinical medicine, and served as deputy chief physician. He has been engaged in oncology for a long time, has nearly 2 0 years of clinical experience in related disciplines, and has in-depth mastery and research on various tumor-related diseases. Advocate biological immunotherapy for tumors, increase patients' immune function, and reduce the side effects of surgery, radiotherapy and chemotherapy on the body. Director of China Cancer Research Foundation, Vice President of CCRF Branch and Director of Anti-cancer Association.

Be especially good at

He has been committed to the research and clinical application of biological immunotherapy for tumors for a long time, and took the lead in advocating the use of biological immunotherapy in Dalian to mobilize the natural anti-cancer ability of the human body, restore the internal environment balance of the body, and prolong the life cycle of tumor patients.

achievements in scientific research

He has published more than 40 papers, edited 3 books and participated in 6 international academic conferences. He once put forward "tumor immune rejection therapy", published more than 10 papers, and won the scientific and technological progress award of Guizhou Province and the national invention patent. Visited the United States and Canada many times. Cancer Control in China has attracted much attention. Participated in the collaboration to complete the "7.5" public relations project, and the anti-radiation and anti-cancer research of Rhizoma Curcumae won the National Science Conference Award.

Personal profile

Graduated from Dalian Medical College from 65438 to 0955, engaged in medical teaching and research for 50 years, and paid more attention to tumor immunology, biological modification therapy, tumor autologous vaccine, tumor regional chemotherapy and multidisciplinary comprehensive treatment. He has served as the director of the department, the director of the teaching and research section, the vice president of the affiliated cancer hospital, and the consultant of the cancer prevention office. Employed by the National Natural Science Foundation of China, he is a member of the life science group and the tumor biological immunity project evaluation group, and has participated in the evaluation of the National Natural Science Foundation for three consecutive years. In his later years, he proposed "Reasonably deducing the cancer screening method". Deputy chief physician of oncology department; Member of the blood professional Committee of the whole army; Master tutor of Dalian Medical University

Be especially good at

Good at comprehensive treatment of tumor diseases, blood system diseases and systemic lupus erythematosus; It is advocated to formulate a scientific, standardized and individualized treatment plan according to the patient's physical condition.

achievements in scientific research

He published more than 50 academic papers, participated in the compilation of monographs "Treatment of Leukemia in Modern Chinese Medicine" and "Theory and Practice of Tumor Biotherapy", and participated in and won 5 scientific and technological progress awards and 2 medical achievement awards from Dalian Municipal Government, Liaoning Provincial Education Commission, Liaoning Provincial Government and the whole army. Related papers won the first prize of excellent papers of Shanghai Society of Integrated Traditional Chinese and Western Medicine Cancer Branch, and related articles were reprinted by Shanghai Anti-cancer Association and China Traditional Chinese Medicine Publishing House.

Personal profile

Graduated from Shanghai Second Military Medical University with a doctorate in integrated traditional Chinese and western medicine. In recent years, the comprehensive treatment of malignant tumors, especially the autologous cell therapy technology of malignant tumors, has unique insights. It has helped many cancer patients achieve the treatment goal of prolonging life time and improving quality of life, and made outstanding contributions to the field of cancer treatment in our province.